Literature DB >> 23559323

[Influence of postoperative oral steroid treatment on retinal sensitivity in patients after macular surgery. A randomized, controlled, clinical trial].

S Rezar1, S Sacu, M Ritter, W Bühl, M Georgopoulos, U Schmidt-Erfurth, C Prünte.   

Abstract

BACKGROUND: The aim of this study was to evaluate the effect of postoperative systemic steroid treatment on retinal sensitivity in patients with epiretinal membrane (ERM) after successful surgery. PATIENTS AND METHODS: A total of 28 patients with ERM, macular edema and visual loss were included in this study. All patients were treated with combined 23 gauge vitrectomy and peeling of the ERM and inner limiting membrane (ILM). After randomization the first group (n = 14) was treated with postoperative systemic steroids (100 mg prednisolone per day for 5 days) and the second group (n = 14) served as a control group. Follow-up examinations were performed up to 12 months.
RESULTS: After 12 months a statistically significant increase in visual acuity with a gain of 17/10 letters in the steroid/control group as well as significant decrease of the central retinal thickness of 107/128 µm could be observed (p < 0.05). In the steroid/control group mean retinal sensitivity increased from 14.0/14.3 dB after 12 months in comparison to 11.7/11.9 dB at baseline examination (p < 0.05).
CONCLUSIONS: Postoperative oral steroid treatment does not seem to be beneficial in patients with macular pucker surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23559323     DOI: 10.1007/s00347-012-2763-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  25 in total

1.  Structural and functional predictors of visual outcome of epiretinal membrane surgery.

Authors:  Ji Hyun Kim; Yong Min Kim; Eun Jee Chung; Soo Young Lee; Hyoung Jun Koh
Journal:  Am J Ophthalmol       Date:  2011-09-19       Impact factor: 5.258

Review 2.  Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review.

Authors:  W E Smiddy; R G Michels; W R Green
Journal:  Retina       Date:  1990       Impact factor: 4.256

3.  Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

Authors:  Osman Cekiç; Stanley Chang; Joseph J Tseng; Gaetano R Barile; Harold Weissman; Lucian V Del Priore; William M Schiff; Michael Weiss; James M Klancnik
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

4.  Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.

Authors:  David S Boyer; David Faber; Sunil Gupta; Sunil S Patel; Homayoun Tabandeh; Xiao-Yan Li; Charlie C Liu; Jean Lou; Scott M Whitcup
Journal:  Retina       Date:  2011-05       Impact factor: 4.256

5.  Prognostic factors in vitrectomy for epiretinal membranes of the macula.

Authors:  T A Rice; S De Bustros; R G Michels; J T Thompson; S M Debanne; D Y Rowland
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

6.  Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.

Authors:  Takanori Kameda; Kazuaki Nishijima; Noriyuki Unoki; Atsushi Sakamoto; Hisako Hayashi; Hideyasu Oh; Mihori Kita; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-24       Impact factor: 3.117

7.  SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.

Authors:  Gabriel Coscas; Florence Coscas; Ilaria Zucchiatti; Agnes Glacet-Bernard; Gisele Soubrane; Eric Souïed
Journal:  Eur J Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 2.597

8.  Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.

Authors:  Fevzi Senturk; Hakan Ozdemir; Murat Karacorlu; Serra Arf Karacorlu; Omer Uysal
Journal:  Retina       Date:  2010-09       Impact factor: 4.256

9.  Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema.

Authors:  Ingrid U Scott; Harry W Flynn; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

10.  Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study.

Authors:  Samantha Fraser-Bell; Magdalena Guzowski; Elena Rochtchina; Jie Jin Wang; Paul Mitchell
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.